Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Overview

This study describes a phosphoflow cytometry-based method used to analyze the signaling pathways downstream of mTORC1, JAK/STAT5, and MAPK in acute human myeloid leukemia cells. The model system involves xenografting these cells into mice, utilizing samples obtained from bone marrow aspirates. Key signaling molecules including p-STAT5, p-4EBP1, p-RPS6, and p-ERK1/2 are measured with a next-generation spectral flow cytometer that offers high sensitivity.

Key Study Components

Research Area

• Signal transduction in cancer
• Acute myeloid leukemia research
• Phosphoflow cytometry techniques

Background

• Understanding leukemia cell signaling for therapeutic development
• Importance of mTORC1, JAK/STAT5, and MAPK pathways in cancer
• Limitations of traditional flow cytometry techniques

Methods Used

• Phosphoflow cytometry
• Acute human myeloid leukemia cells in mouse xenograft model
• Next-generation spectral flow cytometry for sensitive detection

Main Results

• Successful measurement of multiple phosphorylated signaling proteins
• Demonstration of pathway activation in leukemia cells
• Insights into the intersection of these signaling pathways

Conclusions

• This study demonstrates a novel approach to investigate leukemia signaling pathways.
• Findings have implications for targeted therapies in cancer research.

Frequently Asked Questions